SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : DRUG: Dragon Pharmaceutical
DRUG 54.480.0%Oct 31 9:30 AM EST
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: drugob who wrote (24)3/19/2005 2:01:35 PM
From: konasurfs1968  Read Replies (1) of 28
 
Here is a thread for other China plays, you'll have to sift through them and see if there are any biotech's listed. I believe there are a couple there, although they are not true boitech firms (more processing type bio's like AOBO.OB).

Subject 53604

Dragon is the only publicly traded co. that I know of that is manufacturing and marketing their own generic EPO. However, just last month PLIVA in Europe announced their intentions of the same as it relates to generic EPO. Apparently, PLIVA is a major generic pharma, so they will most likely have EU foothold once they begin their own ramp maynegroup.com.

Dragon needs to put their new salesforce to work immediately to begin ramping generic EPO sales in the countries they have been approved to sell EPO in. We should see results to that end in a couple of Q's.

Be aware of short term weakness in DRUG.OB. Lots of newly acquired shares by new insiders and they will sell to get quick cash. Dragon is also listed on the Berlin exchange (not sure why they allowed that as it is well known the naked short sellers thrive there). Drop should occur shortly, based on trading action past couple of weeks. When it does, I plan on taking advantage of it along with a few others.

By the end of this year, DRUG.OB has a shot at trading near $3.00 as revenues of EPO begin to increase in earnest. We'll see.

Regards
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News